Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 3/20 | 0.55 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31578852 | 0.88 | FASN (0.69) | FASNPLA2G2APLA2G5IMPDH2 | |
| SCHEMBL30550308 | 0.88 | FASN (0.69) | FASNPLA2G2APLA2G5IMPDH2 | |
| SCHEMBL34468687 | 0.88 | FASN (0.52) | FASNPLA2G2APLA2G5 | |
| SCHEMBL34468645 | 0.87 | FASN (0.51) | FASNPLA2G2A | |
| SCHEMBL34468665 | 0.85 | FASN (0.49) | FASNPLA2G2A | |
| SCHEMBL34468632 | 0.83 | FASN (0.47) | FASNPLA2G2A | |
| SCHEMBL34468661 | 0.83 | FASN (0.47) | FASN | |
| SCHEMBL34468633 | 0.83 | FASN (0.47) | FASN | |
| SCHEMBL31232367 | 0.81 | FASN (0.59) | FASNPLA2G2APLA2G5IMPDH2 | |
| SCHEMBL30550331 | 0.81 | FASN (0.59) | FASNPLA2G2APLA2G5IMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260115152-A1 | AGRIMOL B DERIVATIVES AND METHODS OF MAKING AND USE THEREOF | Laboratory for Synthetic Chemistry and Chemical Biology Limited (CN) | 2026-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115152-A1 | AGRIMOL B DERIVATIVES AND METHODS OF MAKING AND USE THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AR, MCL1 | FASN 2296/4885PLA2G2A 3359/4885PLA2G5 3460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.